<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties manuscript?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">7807270</journal-id><journal-id journal-id-type="pubmed-jr-id">22115</journal-id><journal-id journal-id-type="nlm-ta">Environ Int</journal-id><journal-id journal-id-type="iso-abbrev">Environ Int</journal-id><journal-title-group><journal-title>Environment international</journal-title></journal-title-group><issn pub-type="ppub">0160-4120</issn><issn pub-type="epub">1873-6750</issn></journal-meta><article-meta><article-id pub-id-type="pmid">28689110</article-id><article-id pub-id-type="pmc">5633368</article-id><article-id pub-id-type="doi">10.1016/j.envint.2017.06.019</article-id><article-id pub-id-type="manuscript">HHSPA897951</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Persistent organic pollutants in infants and toddlers: Relationship between concentrations in matched plasma and faecal samples</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Yiqin</given-names></name><xref ref-type="aff" rid="A1">a</xref><xref ref-type="author-notes" rid="FN1">*</xref></contrib><contrib contrib-type="author"><name><surname>Sjodin</surname><given-names>Andreas</given-names></name><xref ref-type="aff" rid="A2">b</xref></contrib><contrib contrib-type="author"><name><surname>McLachlan</surname><given-names>Michael S.</given-names></name><xref ref-type="aff" rid="A3">c</xref></contrib><contrib contrib-type="author"><name><surname>English</surname><given-names>Karin</given-names></name><xref ref-type="aff" rid="A4">d</xref></contrib><contrib contrib-type="author"><name><surname>Aylward</surname><given-names>Lesa L.</given-names></name><xref ref-type="aff" rid="A1">a</xref><xref ref-type="aff" rid="A5">e</xref></contrib><contrib contrib-type="author"><name><surname>Toms</surname><given-names>Leisa-Maree L.</given-names></name><xref ref-type="aff" rid="A6">f</xref></contrib><contrib contrib-type="author"><name><surname>Varghese</surname><given-names>Julie</given-names></name><xref ref-type="aff" rid="A4">d</xref></contrib><contrib contrib-type="author"><name><surname>Sly</surname><given-names>Peter D.</given-names></name><xref ref-type="aff" rid="A4">d</xref></contrib><contrib contrib-type="author"><name><surname>Mueller</surname><given-names>Jochen F.</given-names></name><xref ref-type="aff" rid="A1">a</xref></contrib></contrib-group><aff id="A1">
<label>a</label>Queensland Alliance for Environmental Health Sciences, The University of Queensland, Australia</aff><aff id="A2">
<label>b</label>Centers for Disease Control and Prevention, Atlanta, GA, USA</aff><aff id="A3">
<label>c</label>Department of Environmental Science and Analytical Chemistry (ACES), Stockholm University, Sweden</aff><aff id="A4">
<label>d</label>Children&#x02019;s Health and Environment Program, Child Health Research Centre, The University of Queensland, Australia</aff><aff id="A5">
<label>e</label>Summit Toxicology, LLP, Falls Church, VA, USA</aff><aff id="A6">
<label>f</label>School of Public Health and Social Work, Institute of Health and Biomedical Innovation, Faculty of Health, Queensland University of Technology, Australia</aff><author-notes><corresp id="FN1"><label>*</label>Corresponding author. <email>celerychenyiqin2017@outlook.com</email> (Y. Chen)</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>14</day><month>9</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>06</day><month>7</month><year>2017</year></pub-date><pub-date pub-type="ppub"><month>10</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>10</month><year>2018</year></pub-date><volume>107</volume><fpage>82</fpage><lpage>88</lpage><!--elocation-id from pubmed: 10.1016/j.envint.2017.06.019--><abstract><p id="P1">Early-childhood biomonitoring of persistent organic pollutants (POPs) is challenging due to the logistic and ethical limitations associated with blood sampling. We investigated using faeces as a non-invasive matrix to estimate internal exposure to POPs. The concentrations of selected POPs were measured in matched plasma and faecal samples collected from 20 infants/toddlers (aged 13 &#x000b1; 4.8 months), including a repeat sample time point for 13 infants (~5 months apart). We observed higher rates of POP quantification in faeces (2 g dry weight) than in plasma (0.5 mL). Among the five chemicals that had quantification frequencies over 50% in both matrices, except for HCB, log concentration in faeces (C<sub>f</sub>) and blood (C<sub>b</sub>) were correlated (r &#x0003e; 0.74, P &#x0003c; 0.05) for <italic>p</italic>.<italic>p</italic>&#x02032;-dichlorodiphenyldichloroethylene (<italic>p</italic>,<italic>p</italic>&#x02032;-DDE), 2,3&#x02032;,4,4&#x02032;,5-pentachlorobiphenyl (PCB118), 2,2&#x02032;,3,4,4&#x02032;,5&#x02032;-penta-chlorobiphenyl (PCB138) and 2,2&#x02032;,4,4&#x02032;,5,5&#x02032;-pentachlorobiphenyl (PCB153). We determined faeces:plasma concentration ratios (K<sub>fb</sub>), which can be used to estimate C<sub>b</sub> from measurements of C<sub>f</sub> for infants/toddlers. For a given chemical, the variation in K<sub>fb</sub> across individuals was considerable (CV from 0.46 to 0.70). Between 5% and 50% of this variation was attributed to short-term intra-individual variability between successive faecal samples. This variability could be reduced by pooling faeces samples over several days. Some of the remaining variability was attributed to longer-term intra-individual variability, which was consistent with previously reported observations of a decrease in K<sub>fb</sub> over the first year of life. The strong correlations between C<sub>f</sub> and C<sub>b</sub> demonstrate the promise of using faeces for biomonitoring of these compounds. Future research on the sources of variability in K<sub>fb</sub> could improve the precision and utility of this technique.</p></abstract><kwd-group><kwd>POPs</kwd><kwd>Non-invasive bio-monitoring</kwd><kwd>Infants</kwd><kwd>Toddlers</kwd><kwd>Faeces</kwd><kwd>Blood</kwd></kwd-group></article-meta></front><body><sec id="S1"><title>1. Introduction</title><p id="P2">The burden of chronic diseases has been rapidly increasing during the past decades (<xref rid="R8" ref-type="bibr">IHME, 2013</xref>) and risk factors occurring during the developmental period are now recognized to play an important role (<xref rid="R1" ref-type="bibr">Barker, 2004</xref>). The mechanisms implicated in developmental programming of chronic disorders are poorly understood, but epigenetic mechanisms are likely involved (<xref rid="R5" ref-type="bibr">Hanson and Gluckman, 2015</xref>). Exposure to environmental xenobiotics is suggested to be one of the triggers for epigenetic changes, especially during sensitive early life stages (<xref rid="R16" ref-type="bibr">Nickerson, 2006</xref>; <xref rid="R10" ref-type="bibr">Kortenkamp et al., 2011</xref>; <xref rid="R25" ref-type="bibr">Vaiserman, 2015</xref>). Persistent organic pollutants (POPs) including polychlorinated biphenyls (PCBs), organochlorine pesticides (OCPs) and polybrominated diphenyl ethers (PBDEs), are a group of environmental xenobiotics that are resistant to degradation and bioaccumulate in humans, and have been shown to induce epigenetic changes (<xref rid="R6" ref-type="bibr">Herbstman et al., 2010</xref>; <xref rid="R26" ref-type="bibr">Valvi et al., 2012</xref>; <xref rid="R4" ref-type="bibr">Eskenazi et al., 2013</xref>).</p><p id="P3">All POPs that are listed on the Stockholm Convention have been banned or substantially restricted in their use in many countries. For many POPs like PCBs, OCPs, tetrabromodiphenyl ether and pentabromodiphenyl ether, a decrease in exposure and associated body burden has been observed in some parts of the world (<xref rid="R12" ref-type="bibr">Law et al., 2014</xref>; <xref rid="R13" ref-type="bibr">Mike&#x00161; et al., 2012</xref>). Nonetheless, exposure and accumulation will continue for decades to come (<xref rid="R7" ref-type="bibr">Hung et al., 2016</xref>; <xref rid="R18" ref-type="bibr">Ryan and Rawn, 2014</xref>; <xref rid="R20" ref-type="bibr">Sharma et al., 2014</xref>; <xref rid="R24" ref-type="bibr">Toms et al., 2012</xref>). Therefore, research continues into whether adverse effects from POPs are occurring at the current levels of exposure and whether extra actions should be taken to reduce exposure (<xref rid="R16" ref-type="bibr">Nickerson, 2006</xref>). In order to answer these questions, it is vital to be able to quantify exposure during critical exposure windows, including during the early stages of life (<xref rid="R11" ref-type="bibr">La Merrill et al., 2013</xref>).</p><p id="P4">For infants and toddlers, individual and longitudinal data on POP concentrations in blood samples are scarce, due to the logistic and ethical constraints regarding sampling blood in these age groups (<xref rid="R15" ref-type="bibr">Needham et al., 2005</xref>). Faeces can be obtained from infants/toddlers less invasively and more conveniently than blood, and therefore may be useful for early-life biomonitoring. In toddlers, significant correlations between congener-specific concentrations in faeces and serum were found for seven of nine PBDE congeners studied (<xref rid="R19" ref-type="bibr">Sahlstrom et al., 2015</xref>). Concentrations of <italic>p</italic>,<italic>p</italic>&#x02032; DDE and PCB153 in faeces collected from one infant over a period of one year were reported to be more reflective of estimated body burden than of rate of dietary intake at the time of faecal sample collection (<xref rid="R3" ref-type="bibr">Chen et al., 2016</xref>). Those results are in accordance with findings from studies of POPs in adults that showed that POP levels in faeces are not influenced by current dietary intake levels, but are instead governed by levels in the body (<xref rid="R17" ref-type="bibr">Rohde et al., 1999</xref>; <xref rid="R22" ref-type="bibr">To-Figueras et al., 2000</xref>; <xref rid="R14" ref-type="bibr">Moser and McLachlan, 2001</xref>).</p><p id="P5">Furthermore, it has been demonstrated in adults that the POP concentration in faeces is highly correlated with the POP concentration in blood, while the influence of the mass of faeces excreted each day on POP concentration in faeces is minor in comparison (<xref rid="R14" ref-type="bibr">Moser and McLachlan, 2001</xref>). On the basis of this work, <xref rid="R14" ref-type="bibr">Moser and McLachlan (2001)</xref> suggested that the ratio of POP concentrations in faeces to blood (K<sub>fb</sub>) is a parameter of considerable practical value for estimating the concentrations of POPs in the body. However, before this method can be reliably used to estimate infants and toddlers POP body burden, more data regarding how K<sub>fb</sub> varies during the early years are required. Although variations in K<sub>fb</sub> have been observed between individuals (<xref rid="R19" ref-type="bibr">Sahlstrom et al., 2015</xref>), between chemicals and between pre- and post-weaning in the same individual (<xref rid="R3" ref-type="bibr">Chen et al., 2016</xref>), no studies have quantified the relative contributions of intra- and inter-individual variability to the overall variation in K<sub>fb</sub>.</p><p id="P6">In this study, the concentrations of several OCPs, PCB congeners and PBDE congeners were measured in matched plasma and faecal samples from 20 infants/toddlers at two time points. The relationship between the concentrations in plasma (C<sub>b</sub>) and the concentrations in faeces (C<sub>f</sub>) was then assessed via both linear regression and variability analysis of K<sub>fb</sub>. The study was designed to allow comparison of the intra- and inter-individual variation in K<sub>fb</sub>, with the goal of investigating further the potential utility of faeces as a non-invasive matrix for biomonitoring POPs in infants and toddlers.</p></sec><sec id="S2"><title>2. Methods</title><sec id="S3"><title>2.1. Study participants</title><p id="P7">The participants (infants/toddlers [n = 20]) in this study were recruited from the ongoing study &#x0201c;A phase 2, single-centre, double blind, randomized, placebo-controlled study testing the primary prevention of persistent asthma in high risk children by protection against acute respiratory infections during early childhood using OM-85&#x0201d; (OMPAC). The inclusion/exclusion criteria for the OMPAC study are shown in <xref ref-type="supplementary-material" rid="SD1">Table S1</xref>.</p><p id="P8">For the analysis of the long-term variation in K<sub>fb</sub>, participants were asked to donate samples twice for the present study. The first sample collection occurred in April 2014 while the second occurred in September 2014. At each sampling time, one plasma sample of ~0.5 mL and faecal samples from 1 to 2 bowel movements (~2 g dry weight [dw]) were collected from each participant, and a questionnaire regarding living and eating habits was completed by their parents. Participants were not required to fast before the blood samples were conducted. Thirteen participants completed two sample periods. Four participants provided a sample only in the first sample period, while three participated only in the second.</p><p id="P9">If a faeces sample was smaller than 1 g dw, it was combined with the other faeces sample from the same sampling day prior to extraction. Otherwise the two faeces samples from the same sampling day (from participants No. 5, 20 and 22 from the first sampling, and participants No. 2, 3, 8, 10, 15 and 16 from the second sampling) were analysed separately to provide information regarding the short-term variation in K<sub>fb</sub>.</p><p id="P10">This study received ethics approval by the University of Queensland Ethics Committee (approval number H/308NRCET/00) and Children&#x02019;s Health Services Queensland Human Research Ethics Committee (HREC reference number: HREC/12/QRCH/119). The Centers for Disease Control and Prevention (CDC) were determined not to be engaged in human subject research since no personally identifiable information was made available to CDC researchers.</p></sec><sec id="S4"><title>2.2. Sampling</title><p id="P11">Blood was collected into a polypropylene tube with 100 units of preservative free heparin. It was then processed as follows to obtain plasma: (i) centrifuging at 700 &#x000d7;<italic>g</italic> for 10 min at room temperature; (ii) collecting the plasma layer down to within 0.5&#x02013;1.0 cm of the top of the red cell layer (avoiding disturbance of white cells) using a sterile transfer pipette; (iii) centrifuging the plasma again at 700 &#x000d7;<italic>g</italic> for 10 mins to remove platelets; (iv) transferring the plasma sample into a brown Eppendorf tube and storing at &#x02212;80 &#x000b0;C.</p><p id="P12">Faecal samples for each participant were collected from one to two defecation events directly before and after the blood sampling. At each sampling point, only faecal material that had not been in contact with the inner liner of the diaper was transferred to a sheet of aluminium foil. The folded aluminium foil sheet was then sealed inside a plastic resealable bag and stored in a freezer at the participant&#x02019;s home until transportation to the laboratory (on ice, in a cool bag). A detailed description of faecal sample collection and transportation has been provided previously (<xref rid="R2" ref-type="bibr">Chen et al., 2015</xref>). Faecal samples were stored at &#x02212;20 &#x000b0;C until analysis.</p></sec><sec id="S5"><title>2.3. Analysis</title><p id="P13">Analysis included four chlorinated pesticides (<italic>p</italic>,<italic>p</italic>&#x02032; DDE, HCB, &#x003b2;-HCH, &#x003b3;-HCH), five PCB congeners (PCB28, 118, 138, 153 and 180) and five PBDE congeners (PBDE 47, 99, 100, 153 and 154) in plasma and faecal samples. All brown Eppendorf tubes containing plasma samples were sent to the Centers for Disease Control and Prevention (CDC), USA, on dry ice for analysis. POPs were measured in individual plasma samples using a methodology published previously (<xref rid="R9" ref-type="bibr">Jones et al., 2012</xref>; <xref rid="R21" ref-type="bibr">Sjodin et al., 2004</xref>). POPs were measured in faeces using a previously described method (<xref rid="R2" ref-type="bibr">Chen et al., 2015</xref>). Detailed description of the methods can be found in the <xref ref-type="supplementary-material" rid="SD1">Table S2</xref>.</p></sec><sec id="S6"><title>2.4. Quality control</title><p id="P14">Quality control procedures for plasma and faeces samples included method blanks and spiked samples. Additional details of quality control procedures and determination of limits of detection (LOD) and quantification (LOQ) are provided in <xref ref-type="supplementary-material" rid="SD1">Table S3</xref>. The average recoveries of the labelled standards ranged from 61% to 93% for all chemicals (<xref ref-type="supplementary-material" rid="SD1">Table S4</xref>). Only results that were above the LOQ were used in the regression analysis. A more conservative criterion for quantification was used for faecal samples because the variability in matrix properties contributes to a higher uncertainty in the measurements. For summarizing data, results for plasma below the LOQ were imputed as LOQ/(2)<sup>1/2</sup>; results for faeces below the LOD were imputed as LOD/(2)<sup>1/2</sup> and for faeces between the LOD and the LOQ were imputed as the average of LOD and LOQ.</p><p id="P15">Concentrations of target POPs in faeces were determined on both a dry-weight (dw) and lipid-weight basis. In those cases where two samples from the same day were analysed (<xref ref-type="supplementary-material" rid="SD1">Table S5</xref>), the dry-weight based concentrations of POPs in a given individual were more consistent than lipid-weight based concentrations (paired <italic>t</italic>-test done on percent differences of both lipid-based and dry-weight based data, P = 0.005, n = 38). Therefore, the dry-weight based concentrations in faecal samples were used for the data analysis. In the following text, C<sub>b</sub> and C<sub>f</sub> represent the lipid-weight normalized concentration in plasma and dry-weight normalized concentration in faeces, respectively.</p></sec><sec id="S7"><title>2.5. Statistical analysis</title><p id="P16">The K<sub>fb</sub> was calculated according to the following formula:
<disp-formula id="FD1"><mml:math id="M1" display="block" overflow="scroll"><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mtext>fb</mml:mtext></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi mathvariant="normal">C</mml:mi><mml:mi mathvariant="normal">f</mml:mi></mml:msub><mml:mspace width="0.2em"/><mml:mo stretchy="false">(</mml:mo><mml:mtext>ng</mml:mtext><mml:mo>/</mml:mo><mml:mtext>gdw</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">C</mml:mi><mml:mi mathvariant="normal">b</mml:mi></mml:msub><mml:mspace width="0.2em"/><mml:mo stretchy="false">(</mml:mo><mml:mtext>ng</mml:mtext><mml:mo>/</mml:mo><mml:mtext>glipid</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac></mml:math></disp-formula></p><p id="P17">Due to the varying number of samples that were collected from each participant, the data from one sampling time point from an individual (who participated at both sampling time points) was randomly chosen to form a restricted cross-sectional dataset (n = 20) for the linear-regression analyses of C<sub>b</sub> and C<sub>f</sub>. Short-term (&#x0003c; 24 h) variability in K<sub>fb</sub> was assessed using data from a sub-group of participants (n = 7) who provided two faecal samples within a 24-hour period. For each of these individuals, the same C<sub>b</sub> was used to derive both K<sub>fb</sub> values. The intra-individual variance in K<sub>fb</sub> (the percent difference between the two values) was then calculated as well for this sub-group. To assess the relative contributions of intra-individual variation and inter-individual variation to short-term variability in K<sub>fb</sub>, the intra-class correlation coefficient (ICC) was determined. ICC is calculated as the ratio of the between-individual variance to the total variance (sum of between- and within-individual variance) in a set of data with repeated measures for individuals. ICC values provide a measure of reproducibility for repeated measures and vary between 0 and 1, with 0 indicating no reproducibility and 1 indicating perfect reproducibility. The relative contributions of intra- and inter-individual variation to long-term variability in K<sub>fb</sub> was also assessed by determining the ICC in a subgroup of participants (n = 13) who provided faecal and blood samples at two sampling periods (~5 months apart).</p><p id="P18">Linear-regression analyses of the relationship between C<sub>b</sub> and C<sub>f</sub>, and ANOVA of K<sub>fb</sub> among chemicals were performed using GraphPad Prism 6 (GraphPad Software, Inc., USA). The intra-class correlation coefficient (ICC) was determined using SPSS Statistics 23 (Chicago, USA). Other statistical evaluation of the analytical and demographical data was performed using Microsoft Excel 2013 (Microsoft, Redmond, WA, USA).</p></sec></sec><sec id="S8"><title>3. Results</title><p id="P19">The chemical-specific analytical results are shown in <xref ref-type="supplementary-material" rid="SD1">Tables S6</xref> and <xref ref-type="supplementary-material" rid="SD1">S7</xref>. Eight chemicals (&#x003b2;-HCH, &#x003b3;-HCH, PCB28, PCB180, BDE99, BDE100, BDE153 and BDE154) were not included for regression analysis due to low quantification frequencies in both plasma and faecal samples. The quantification frequency of BDE47 was 88% in faeces but only 12% in plasma and hence it was not included in the regression analysis either.</p><sec id="S9"><title>3.1. Cohort information</title><p id="P20">The participants were evenly distributed in terms of sex and delivery type. The majority of participants (60%) were weaned before the first sampling period. The average age of the participants was 13 months (ranging from 5.6 months to 24 months) for the cross-sectional dataset. One participant took antibiotics within a week before or after sampling, and one participant took antibiotics on the sampling day. No bowel complaints were reported for any participant on the sampling days. Additional details regarding the participating infants and toddlers are presented in <xref ref-type="supplementary-material" rid="SD1">Tables S8</xref>, <xref ref-type="supplementary-material" rid="SD1">S9</xref>, and <xref ref-type="supplementary-material" rid="SD1">S10</xref>.</p></sec><sec id="S10"><title>3.2. Concentrations of POPs in plasma (C<sub>b</sub>) and faeces (C<sub>f</sub>)</title><p id="P21">The cross-sectional dataset (n = 20) that was used for the linear-regression analyses is summarized in <xref ref-type="supplementary-material" rid="SD1">Table S11</xref>. The C<sub>b</sub> of four chlorinated pesticides (<italic>p</italic>,<italic>p</italic>&#x02032;-DDE, HCB, &#x003b2;-HCH and &#x003b3;-HCH), five PCB congeners (PCB28, 118, 138, 153 and 180) and five PBDE congeners (BDE 47, 99, 100, 153 and 154) from 20 infants/toddlers are summarized in <xref rid="T1" ref-type="table">Table 1</xref> (more details are summarized in <xref ref-type="supplementary-material" rid="SD1">Table S12</xref>). In this cross-sectional dataset, <italic>p</italic>,<italic>p</italic>&#x02032; DDE was the only compound quantified in all the plasma samples. HCB, PCB118, 138, 153 and 180 were quantified in 55&#x02013;75% of the samples. Other analysed chemicals were quantified in &#x0003c; 50% of the samples. <italic>p</italic>,<italic>p</italic>&#x02032; DDE had the highest C<sub>b</sub>, followed by HCB and then the PCB congeners. Arithmetic mean values of C<sub>b</sub> were similar to mean lipid-normalized concentrations in the pooled serum sample collected in 2006&#x02013;2007 from Australian infants, except for the BDEs 47, 99 and 100, which had lower concentrations in our dataset (<xref rid="R23" ref-type="bibr">Toms et al., 2009</xref>) (<xref ref-type="supplementary-material" rid="SD1">Fig. S1</xref>).</p><p id="P22">C<sub>b</sub> was not normally distributed for any of the chemicals (D&#x02019;Agostino &#x00026; Person normality test). The C<sub>b</sub> of <italic>p</italic>,<italic>p</italic>&#x02032;-DDE ranged by more than two orders of magnitude (9.6&#x02013;3400 ng/g lipid) among participants. The geometric means of C<sub>b</sub> of PCB 138, 153, 180 and HCB were 2.7, 3.3, 2.0, and 8.8 ng/g lipid, respectively. Concentrations of DDE, HCB, PCB118, 138 and 153 in plasma are plotted against participant age in <xref ref-type="supplementary-material" rid="SD1">Fig. S2</xref>.</p><p id="P23">The C<sub>f</sub> of four chlorinated pesticides (<italic>p</italic>,<italic>p</italic>&#x02032;-DDE, HCB, &#x003b2;-HCH and &#x003b3;-HCH), five PCB congeners (PCB28, 118, 138, 153 and 180) and five PBDE congeners (BDE 47, 99, 100, 153 and 154) in faecal samples from 20 infants/toddlers are also summarized in <xref rid="T1" ref-type="table">Table 1</xref>. <italic>p</italic>,<italic>p</italic>&#x02032;-DDE, HCB and BDE47 were quantified above LOQ in 90% of faecal samples, followed by PCB118 (80%), PCB138 and PCB153 (both 75%). Other analysed chemicals were quantified in &#x0003c; 50% of the samples. <italic>p</italic>,<italic>p</italic>&#x02032;-DDE had the highest concentration in faeces (mean 1.7 ng/g dw), followed by BDE47 (0.37 ng/g dw) and then PCB 153, HCB and other PCB congeners (0.084&#x02013;0.20 ng/g dw).</p><p id="P24">Similar to the results for plasma, C<sub>f</sub> was not normally distributed for any of the chemicals (D&#x02019;Agostino &#x00026; Person normality test). The geometric mean C<sub>f</sub> of <italic>p</italic>,<italic>p</italic>&#x02032; DDE was 0.61 ng/g dw, while for the PCBs ranged from 0.019 to 0.068 ng/g dw. The geometric mean C<sub>f</sub> of HCB was 0.069 ng/g dw, while for the PBDEs it ranged from 0.0019 to 0.20 ng/g dw. The concentrations of DDE, HCB, PCB118, 138 and 153 in faecal samples are plotted for every participant along with their ages in <xref ref-type="supplementary-material" rid="SD1">Fig. S3</xref>.</p></sec><sec id="S11"><title>3.3. Concentrations in faeces in relation to concentrations in matched plasma samples</title><p id="P25">As both C<sub>b</sub> and C<sub>f</sub> are more nearly log-normal than normal, the association between log<sub>10</sub>C<sub>b</sub> and log<sub>10</sub> C<sub>f</sub> was assessed for <italic>p</italic>,<italic>p</italic>&#x02032;-DDE, HCB, PCB118, 138 and 153 using linear regression (see <xref ref-type="supplementary-material" rid="SD1">Tables S13</xref> and <xref ref-type="supplementary-material" rid="SD1">S14</xref>). The regressions were significant with values of r<sup>2</sup> ranging from 0.55 to 0.77, except for HCB (r<sup>2</sup>of 0.022). These relationships are illustrated in <xref rid="F1" ref-type="fig">Fig. 1</xref>.</p><p id="P26">The K<sub>fb</sub> values for all plasma-faeces sample pairs are shown in <xref ref-type="supplementary-material" rid="SD1">Table S15</xref>. Summary statistics for the faeces:blood concentration ratios (K<sub>fb</sub>) determined from the cross-sectional dataset are shown in <xref ref-type="supplementary-material" rid="SD1">Tables S16</xref> and <xref ref-type="table" rid="T2">2</xref>. The K<sub>fb</sub> values were normally distributed for <italic>p</italic>,<italic>p</italic>&#x02032;-DDE, HCB and PCB138 (D&#x02019;Agostino &#x00026; Pearson normality test). The mean K<sub>fb</sub> values for <italic>p</italic>,<italic>p</italic>&#x02032;-DDE, HCB and PCB138 were 0.0081, 0.024 and 0.018, respectively. The coefficient of variation (CV) of K<sub>fb</sub> was 47%, 66% and 57% for <italic>p</italic>,<italic>p</italic>&#x02032;-DDE, HCB, and PCB138, respectively. The K<sub>fb</sub> values for PCB 118 and PCB 153 ranged from 0.010 to 0.11 and 0.0072 to 0.073, respectively.</p></sec><sec id="S12"><title>3.4. Sources of variability in K<sub>fb</sub></title><p id="P27">The influence of short-term variation in K<sub>fb</sub> was assessed using a sub-group of participants (n = 7) who provided two faeces samples collected successively within a day. These samples were analysed separately. The percentage difference in C<sub>f</sub> between successively collected samples was as high as 48% (<xref ref-type="supplementary-material" rid="SD1">Table S5</xref>). These C<sub>f</sub> data were used to calculate two K<sub>fb</sub> values for each individual, whereby C<sub>b</sub> was assumed to be the same for the two successively collected faecal samples (see <xref rid="T2" ref-type="table">Table 2</xref>). Two-way random absolute agreement ICC coefficients were calculated for the paired K<sub>fb</sub> values for the seven individuals in this subgroup. For HCB and the PCBs, the ICCs ranged from 0.70 to 0.95, indicating that most of the observed variability in K<sub>fb</sub> was due to inter-individual differences, while 5&#x02013;30% was due to short-term variability between the measurements of two successive faecal samples. A lower value of 0.50 was obtained for <italic>p</italic>,<italic>p</italic>&#x02032;-DDE, indicating that half of the observed variability in K<sub>fb</sub> was due to short term variability between two successive faecal-sample measurements.</p><p id="P28">A second sub-group of the participants (n = 13) provided samples collected ~5 months apart, which allowed investigation of the long-term intra-individual variation in K<sub>fb</sub>. The percentage difference between the two K<sub>fb</sub> values intra-individually varied from 18 to 112% for <italic>p</italic>,<italic>p</italic>&#x02032;-DDE, 39 to 100% for HCB, 19 to 59% for PCB118, 13 to 82% for PCB138, and 0 to 75% for PCB153 (see <xref rid="T2" ref-type="table">Table 2</xref>). The two-way random absolute agreement ICC values were above 0.84 and 0.85 for PCB 118 and 153, respectively, indicating that ~15% of the observed whole variability in K<sub>fb</sub> was due to intra-individual variability. The ICC values for DDE, HCB and PCB 138 were 0.32, 0.50 and 0.47, respectively, indicating that 50% or more of the total variability was due to intra-individual variability for these chemicals.</p></sec></sec><sec id="S13"><title>4. Discussion</title><p id="P29">Compared to blood, using faeces for POP biomonitoring in infants/toddlers has the benefit of easier access to sufficient sample volumes to quantify the contaminants. The 2 g of faeces in our study contained 6 times more <italic>p</italic>,<italic>p</italic>&#x02032;-DDE than 0.5 mL of plasma (equivalent to about 1 mL of blood) (<xref ref-type="supplementary-material" rid="SD1">Fig. S4</xref>). Since a larger effective sample size can be achieved for faecal samples, it allows for quantification at lower concentrations for DDE and other contaminants with comparable or higher K<sub>fb</sub> values.</p><sec id="S14"><title>4.1. The relationship between C<sub>f</sub> and C<sub>b</sub></title><p id="P30">For the five compounds with high quantification frequencies in both matrices, the log-transformed C<sub>b</sub> and C<sub>f</sub> values were significantly and linearly correlated for <italic>p</italic>,<italic>p</italic>&#x02032;-DDE, PCB118, 138, and 153. The 95% confidence intervals of the slope of the log-log regression included one for all four chemicals, consistent with a linear relationship between C<sub>b</sub> and C<sub>f</sub>. For HCB the correlation was not significant. This may be due to the fact that HCB had the narrowest ranges in C<sub>b</sub> and C<sub>f</sub> and all of the data were close to the LOD/LOQ (<xref rid="F1" ref-type="fig">Fig. 1</xref>). The K<sub>fb</sub> value for <italic>p</italic>,<italic>p</italic>&#x02032;-DDE was significantly different from the K<sub>fb</sub> values for the three PCB congeners (one-way ANOVA, Friedman test, P &#x0003c; 0.001). This may reflect the different sorptive capacities of the faeces for the different compounds. This indicates that chemical-specific K<sub>fb</sub> values are needed for biomo-nitoring purposes.</p></sec><sec id="S15"><title>4.2. Sources of intra-individual variability in K<sub>fb</sub></title><p id="P31">The utility of faeces as a biomonitoring tool is dependent on having an accurate and precise estimate of K<sub>fb</sub>. The overall variability in K<sub>fb</sub> was high; the variation of K<sub>fb</sub> in the cross-sectional dataset ranged from a CV of 0.46 to 0.70. ICC assessment showed that both short-term intra-individual variability and long-term intra-individual variability contribute significantly to the overall variability in K<sub>fb</sub>. The low variation of replicate C<sub>f</sub> measurements in the QA sample (a pooled faecal sample with concentrations similar to the real samples; <xref ref-type="supplementary-material" rid="SD1">Table S4</xref> and <xref ref-type="supplementary-material" rid="SD1">Fig. S5</xref>) indicates that the short-term variability is not largely attributable to analytical uncertainty. Rather, short-term variability may be attributable to variability in the digestive process on the scale of hours/meals (because these variables could affect the sorption properties of the lumen contents). This short-term variability could be reduced by pooling samples over longer periods of time. In previous studies with adults, faeces samples were pooled over 3 days, and the inter-individual variability in K<sub>fb</sub> was smaller than in this study. For instance, the CV of K<sub>fb</sub> for PCB153 was 0.44 for adults (<xref rid="R14" ref-type="bibr">Moser and McLachlan, 2001</xref>), while it was 0.70 for infants/toddlers in this study.</p><p id="P32">The intra-individual variability observed in individuals who provided samples 5 months apart could be due to the short-term variability discussed above. It is also possible that it was partly due to changes occurring over a longer time period. Long-term intra-individual variability was observed in our previous study, where K<sub>fb</sub> of PCB153, BDE 47 and <italic>p</italic>,<italic>p</italic>&#x02032;-DDE in a single infant decreased by more than an order of magnitude between the age of 4 months and 12 months. It was hypothesized that the change in diet during weaning changed the properties of faeces and consequently contributed to this decrease (<xref rid="R3" ref-type="bibr">Chen et al., 2016</xref>). In the current study, the mean K<sub>fb</sub> values of <italic>p</italic>,<italic>p</italic>&#x02032;-DDE declined slightly with age (<xref ref-type="supplementary-material" rid="SD1">Fig. S6</xref>), but no significant trends with age were found for the other studied chemicals. Meanwhile, the mean K<sub>fb</sub> was lower for the weaned group (except for HCB), but the difference was not significant (<xref ref-type="supplementary-material" rid="SD1">Fig. S7</xref>). There is a good agreement between K<sub>fb</sub> for participants that were aged &#x0003e; 8 months in this study and the earlier study (<xref ref-type="supplementary-material" rid="SD1">Fig. S8</xref>). Variability in K<sub>fb</sub> could possibly be reduced by focusing on toddlers with a narrower age range and more clearly defined weaning status.</p></sec><sec id="S16"><title>4.3. Source of inter-individual variability in K<sub>fb</sub></title><p id="P33">The ICC analysis indicates that some of the variability in K<sub>fb</sub> is due to inter-individual differences. A variety of factors could contribute to inter-individual variability in K<sub>fb</sub>, including long-term differences in dietary composition that could influence faecal properties (e.g., high fiber vs. low fiber) or differences in gut microflora. This study was not designed to investigate the sources of inter-individual variability in K<sub>fb</sub>. However, our results provided some insight into whether microflora composition has a strong influence on K<sub>fb.</sub>. Two participants (No. 15 and 23) had taken antibiotics shortly before the sampling time point. Although this likely strongly affected the gut microflora, the K<sub>fb</sub> values were similar to both the values from the second sampling of the same participants and to the values of the other participants (with one exception: participant No. 15 had a markedly lower K<sub>fb</sub> for <italic>p</italic>,<italic>p</italic>&#x02032;-DDE). These two cases suggest that microflora composition may not strongly influence K<sub>fb</sub>.</p><p id="P34">Previously, <xref rid="R19" ref-type="bibr">Sahlstrom et al. (2015)</xref> investigated the feasibility of faeces for biomonitoring of PBDEs in toddlers. Tri-decaBDEs were determined in faeces from 22 toddlers and compared to matched serum samples. They developed linear regression models of ln transformed C<sub>b</sub> versus ln transformed C<sub>f</sub>. In contrast to this study, the slopes of their ln-ln regressions deviated markedly from 1 for many of the PBDE congeners, suggesting that C<sub>b</sub> was not linearly related to C<sub>f</sub>. As the detection frequency of PBDE congeners in plasma was low in the current study, we could not confirm these findings, as we were unable to assess the association of C<sub>b</sub> and C<sub>f</sub> for PBDEs. On the other hand, the variation in K<sub>fb</sub> was similar in the two studies. For instance, the coefficient of variation of K<sub>fb</sub> values was 0.39 for BDE47 and 0.66 for BDE207 in <xref rid="R19" ref-type="bibr">Sahlstrom et al. (2015)</xref>.</p></sec><sec id="S17"><title>4.4. Study limitations</title><p id="P35">The number of participants in this study was relatively small, and in some contexts might be considered a &#x0201c;pilot scale&#x0201d; study. However, the value of this limited sample size must be understood in the context of the ethical and logistical constraints associated with repeated blood collection from infants, and also in the context of the previous research on faeces:blood partitioning of POPs: to our knowledge, no previous study has had &#x0003e; 22 participants, adult or infant, and none has provided repeated evaluations in individuals over time. This study provides insight into the relative importance of intra- and inter-individual variability in K<sub>fb</sub>, but it does not identify the factors responsible for these forms of variability. More work is needed to understand this variability, perhaps structured around hypotheses about the relevance of specific factors. As our understanding of this variability grows, there will be a need to test the methodology on more diverse populations and a broader selection of contaminants.</p><p id="P36">The large proportion of samples with concentrations below the LOQ in plasma was a pronounced limitation in this study. This was partly due to the small plasma volume, which was a consequence of the difficulty in obtaining large volumes of blood from infants and toddlers. This difficulty is indeed a major motivation for this research aimed at developing an alternative biomonitoring method to the analysis of blood, but it also poses a dilemma, constraining the development of alternative biomonitoring methods. Future work could focus on more highly exposed individuals where detection of contaminants in blood may be increased.</p><p id="P37">Despite these limitations, this work provides insight into the potential of faeces for biomonitoring POPs in infants and toddlers. The presence of strong correlations between C<sub>f</sub> and C<sub>b</sub> demonstrate the promise of this technique for <italic>p</italic>,<italic>p</italic>&#x02032;-DDE and several PCB congeners. The considerable variability in K<sub>fb</sub> indicates that there are limits to the technique as we applied it. However, our analysis of the sources of variability suggests that there are ways to improve the precision and make faeces a more powerful biomonitoring tool.</p></sec></sec><sec sec-type="supplementary-material" id="S18"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplemental</label><media xlink:href="NIHMS897951-supplement-Supplemental.docx" orientation="portrait" xlink:type="simple" id="d36e1113" position="anchor"/></supplementary-material></sec></body><back><ack id="S19"><p>The authors would like to thank the parents and the infants for participating in this research, Christine Baduel and Chang He for proof reading. The Queensland Alliance for Environmental Health Science, The University of Queensland gratefully acknowledges the financial support of the Queensland Department of Health. Mueller JF and Toms LML are funded by an ARC Future Fellowship (FF 120100546) and an ARC DECRA (DE12010061), respectively. Karin English is funded by an Australian Government Research Training Program Scholarship.</p></ack><fn-group><fn id="FN2"><p><bold>Disclaimer</bold></p><p>The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention (CDC). Use of trade names is for identification only and does not imply endorsement by the CDC, the Public Health Service, or the US Department of Health and Human Services.</p></fn></fn-group><app-group><app id="APP1"><title>Appendix A. Supplementary data</title><p id="P38"><xref ref-type="supplementary-material" rid="SD1">Supplementary data</xref> to this article can be found online at <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.envint.2017.06.019">http://dx.doi.org/10.1016/j.envint.2017.06.019</ext-link>.</p></app></app-group><ref-list><ref id="R1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barker</surname><given-names>DJ</given-names></name></person-group><year>2004</year><article-title>The developmental origins of adult disease</article-title><source>J Am Coll Nutr</source><volume>23</volume><issue>6 Suppl</issue><fpage>588S</fpage><lpage>595S</lpage><pub-id pub-id-type="pmid">15640511</pub-id></element-citation></ref><ref id="R2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Toms</surname><given-names>LM</given-names></name><name><surname>Gallen</surname><given-names>M</given-names></name><name><surname>Hearn</surname><given-names>L</given-names></name><name><surname>Aylward</surname><given-names>LL</given-names></name><name><surname>McLachlan</surname><given-names>MS</given-names></name><name><surname>Sly</surname><given-names>PD</given-names></name><name><surname>Mueller</surname><given-names>JF</given-names></name></person-group><year>2015</year><article-title>Persistent organic pollutants in matched breast milk and infant faeces samples</article-title><source>Chemosphere</source><volume>118</volume><fpage>309</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">25463255</pub-id></element-citation></ref><ref id="R3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>McLachlan</surname><given-names>MS</given-names></name><name><surname>Kaserzon</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Weijs</surname><given-names>L</given-names></name><name><surname>Gallen</surname><given-names>M</given-names></name><name><surname>Toms</surname><given-names>LML</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Aylward</surname><given-names>LL</given-names></name><name><surname>Sly</surname><given-names>PD</given-names></name><name><surname>Mueller</surname><given-names>JF</given-names></name></person-group><year>2016</year><article-title>Monthly variation in faeces:blood concentration ratio of persistent organic pollutants over the first year of life: a case study of one infant</article-title><source>Environ Res</source><volume>147</volume><fpage>259</fpage><lpage>268</lpage><pub-id pub-id-type="pmid">26918839</pub-id></element-citation></ref><ref id="R4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eskenazi</surname><given-names>B</given-names></name><name><surname>Chevrier</surname><given-names>J</given-names></name><name><surname>Rauch</surname><given-names>SA</given-names></name><name><surname>Kogut</surname><given-names>K</given-names></name><name><surname>Harley</surname><given-names>KG</given-names></name><name><surname>Johnson</surname><given-names>C</given-names></name><name><surname>Trujillo</surname><given-names>C</given-names></name><name><surname>Sj&#x000f6;din</surname><given-names>A</given-names></name><name><surname>Bradman</surname><given-names>A</given-names></name></person-group><year>2013</year><article-title>In utero and childhood polybrominated diphenyl ether (PBDE) exposures and neurodevelopment in the CHAMACOS study</article-title><source>Environ Health Perspect</source><volume>121</volume><fpage>257</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">23154064</pub-id></element-citation></ref><ref id="R5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanson</surname><given-names>MA</given-names></name><name><surname>Gluckman</surname><given-names>PD</given-names></name></person-group><year>2015</year><article-title>Developmental origins of health and disease&#x02014;global public health implications</article-title><source>Best Pract Res Clin Obstet Gynaecol</source><volume>29</volume><fpage>24</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">25225058</pub-id></element-citation></ref><ref id="R6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herbstman</surname><given-names>JB</given-names></name><name><surname>Sj&#x000f6;din</surname><given-names>A</given-names></name><name><surname>Kurzon</surname><given-names>M</given-names></name><name><surname>Lederman</surname><given-names>SA</given-names></name><name><surname>Jones</surname><given-names>RS</given-names></name><name><surname>Rauh</surname><given-names>V</given-names></name><name><surname>Needham</surname><given-names>LL</given-names></name><name><surname>Tang</surname><given-names>D</given-names></name><name><surname>Niedzwiecki</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>RY</given-names></name><name><surname>Perera</surname><given-names>F</given-names></name></person-group><year>2010</year><article-title>Prenatal exposure to PBDEs and neurodevelopment</article-title><source>Environ Health Perspect</source><volume>118</volume><fpage>712</fpage><lpage>719</lpage><pub-id pub-id-type="pmid">20056561</pub-id></element-citation></ref><ref id="R7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hung</surname><given-names>H</given-names></name><name><surname>Katsoyiannis</surname><given-names>AA</given-names></name><name><surname>Brorstrom-Lunden</surname><given-names>E</given-names></name><name><surname>Olafsdottir</surname><given-names>K</given-names></name><name><surname>Aas</surname><given-names>W</given-names></name><name><surname>Breivik</surname><given-names>K</given-names></name></person-group><year>2016</year><article-title>Temporal trends of persistent organic pollutants (pops) in arctic air: 20 years of monitoring under the Arctic Monitoring and Assessment Programme (AMAP)</article-title><source>Environ Pollut</source><volume>217</volume><fpage>52</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">26874550</pub-id></element-citation></ref><ref id="R8"><element-citation publication-type="web"><collab>IHME</collab><year>2013</year><source>The global burden of disease: generating evidence, guiding policy</source><comment><ext-link ext-link-type="uri" xlink:href="https://www.business.unsw.edu.au/research-site/Documents/2013-Global-Burden-of-Disease-Report.pdf">https://www.business.unsw.edu.au/research-site/Documents/2013-Global-Burden-of-Disease-Report.pdf</ext-link></comment></element-citation></ref><ref id="R9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>R</given-names></name><name><surname>Edenfield</surname><given-names>E</given-names></name><name><surname>Anderson</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Sj&#x000f6;din</surname><given-names>A</given-names></name></person-group><year>2012</year><article-title>Semi-automated extraction and cleanup method for measuring persistent organic pollutants in human serum</article-title><source>Organohalogen Compd</source><volume>74</volume><fpage>97</fpage><lpage>98</lpage></element-citation></ref><ref id="R10"><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Kortenkamp</surname><given-names>A</given-names></name><name><surname>Martin</surname><given-names>O</given-names></name><name><surname>Faust</surname><given-names>M</given-names></name><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>Mckinlay</surname><given-names>R</given-names></name><name><surname>Orton</surname><given-names>F</given-names></name><etal/></person-group><year>2011</year><article-title>State of the art assessment of endocrine disruptors</article-title><source>Final report</source><comment><ext-link ext-link-type="uri" xlink:href="http://ec.europa.eu/environment/endocrine/documents/4_SOTA%20EDC%20Final%20Report%20V3%206%20Feb%2012.pdf">http://ec.europa.eu/environment/endocrine/documents/4_SOTA%20EDC%20Final%20Report%20V3%206%20Feb%2012.pdf</ext-link></comment></element-citation></ref><ref id="R11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>La Merrill</surname><given-names>M</given-names></name><name><surname>Emond</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>MJ</given-names></name><name><surname>Antignac</surname><given-names>JP</given-names></name><name><surname>Le Bizec</surname><given-names>B</given-names></name><name><surname>Clement</surname><given-names>K</given-names></name><etal/></person-group><year>2013</year><article-title>Toxicological function of adipose tissue: focus on persistent organic pollutants</article-title><source>Environ Health Perspect</source><volume>121</volume><fpage>162</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">23221922</pub-id></element-citation></ref><ref id="R12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Law</surname><given-names>RJ</given-names></name><name><surname>Covaci</surname><given-names>A</given-names></name><name><surname>Harrad</surname><given-names>S</given-names></name><name><surname>Herzke</surname><given-names>D</given-names></name><name><surname>Abdallah</surname><given-names>MAE</given-names></name><name><surname>Fernie</surname><given-names>K</given-names></name><etal/></person-group><year>2014</year><article-title>Levels and trends of PBDEs and HBCDs in the global environment: status at the end of 2012</article-title><source>Environ Int</source><volume>65</volume><fpage>147</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">24486972</pub-id></element-citation></ref><ref id="R13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mike&#x00161;</surname><given-names>O</given-names></name><name><surname>&#x0010c;upr</surname><given-names>P</given-names></name><name><surname>Koh&#x000fa;t</surname><given-names>L</given-names></name><name><surname>Krskov&#x000e1;</surname><given-names>A</given-names></name><name><surname>&#x0010c;ern&#x000e1;</surname><given-names>M</given-names></name></person-group><year>2012</year><article-title>Fifteen years of monitoring of pops in the breast milk, Czech Republic, 1994&#x02013;2009: trends and factors</article-title><source>Environ Sci Pollut Res</source><volume>19</volume><fpage>1936</fpage><lpage>1943</lpage></element-citation></ref><ref id="R14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moser</surname><given-names>GA</given-names></name><name><surname>McLachlan</surname><given-names>MS</given-names></name></person-group><year>2001</year><article-title>The influence of dietary concentration on the absorption and excretion of persistent lipophilic organic pollutants in the human intestinal tract</article-title><source>Chemosphere</source><volume>45</volume><fpage>201</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">11572612</pub-id></element-citation></ref><ref id="R15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Needham</surname><given-names>LL</given-names></name><name><surname>Barr</surname><given-names>DB</given-names></name><name><surname>Calafat</surname><given-names>AM</given-names></name></person-group><year>2005</year><article-title>Characterizing children&#x02019;s exposures: beyond NHANES</article-title><source>Neurotoxicology</source><volume>26</volume><fpage>547</fpage><lpage>553</lpage><pub-id pub-id-type="pmid">16112320</pub-id></element-citation></ref><ref id="R16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nickerson</surname><given-names>K</given-names></name></person-group><year>2006</year><article-title>Environmental contaminants in breast milk</article-title><source>J Midwifery Womens Health</source><volume>51</volume><fpage>26</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">16399607</pub-id></element-citation></ref><ref id="R17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohde</surname><given-names>S</given-names></name><name><surname>Moser</surname><given-names>GA</given-names></name><name><surname>Papke</surname><given-names>O</given-names></name><name><surname>McLachlan</surname><given-names>MS</given-names></name></person-group><year>1999</year><article-title>Clearance of PCDD/Fs via the gastrointestinal tract in occupationally exposed persons</article-title><source>Chemosphere</source><volume>38</volume><fpage>3397</fpage><lpage>3410</lpage><pub-id pub-id-type="pmid">10390849</pub-id></element-citation></ref><ref id="R18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>JJ</given-names></name><name><surname>Rawn</surname><given-names>DFK</given-names></name></person-group><year>2014</year><article-title>The brominated flame retardants, PBDEs and HBCD, in Canadian human milk samples collected from 1992 to 2005; concentrations and trends</article-title><source>Environ Int</source><volume>70</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">24879366</pub-id></element-citation></ref><ref id="R19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahlstrom</surname><given-names>LM</given-names></name><name><surname>Sellstrom</surname><given-names>U</given-names></name><name><surname>de Wit</surname><given-names>CA</given-names></name><name><surname>Lignell</surname><given-names>S</given-names></name><name><surname>Darnerud</surname><given-names>PO</given-names></name></person-group><year>2015</year><article-title>Feasibility study of feces for noninvasive biomonitoring of brominated flame retardants in toddlers</article-title><source>Environ Sci Technol</source><volume>49</volume><fpage>606</fpage><lpage>615</lpage><pub-id pub-id-type="pmid">25493574</pub-id></element-citation></ref><ref id="R20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>BM</given-names></name><name><surname>Bharat</surname><given-names>GK</given-names></name><name><surname>Tayal</surname><given-names>S</given-names></name><name><surname>Nizzetto</surname><given-names>L</given-names></name><name><surname>Cupr</surname><given-names>P</given-names></name><name><surname>Larssen</surname><given-names>T</given-names></name></person-group><year>2014</year><article-title>Environment and human exposure to persistent organic pollutants (pops) in India: a systematic review of recent and historical data</article-title><source>Environ Int</source><volume>66</volume><fpage>48</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">24525153</pub-id></element-citation></ref><ref id="R21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sjodin</surname><given-names>A</given-names></name><name><surname>Jones</surname><given-names>RS</given-names></name><name><surname>Lapeza</surname><given-names>CR</given-names></name><name><surname>Focant</surname><given-names>JF</given-names></name><name><surname>McGahee</surname><given-names>EE</given-names><suffix>3rd</suffix></name><name><surname>Patterson</surname><given-names>DG</given-names><suffix>Jr</suffix></name></person-group><year>2004</year><article-title>Semiautomated high-throughput extraction and cleanup method for the measurement of polybrominated diphenyl ethers, polybrominated biphenyls, and polychlorinated biphenyls in human serum</article-title><source>Anal Chem</source><volume>76</volume><fpage>1921</fpage><lpage>1927</lpage><pub-id pub-id-type="pmid">15053652</pub-id></element-citation></ref><ref id="R22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>To-Figueras</surname><given-names>J</given-names></name><name><surname>Barrot</surname><given-names>C</given-names></name><name><surname>Sala</surname><given-names>M</given-names></name><name><surname>Otero</surname><given-names>R</given-names></name><name><surname>Silva</surname><given-names>M</given-names></name><name><surname>Ozalla</surname><given-names>MD</given-names></name><name><surname>Herrero</surname><given-names>C</given-names></name><name><surname>Corbella</surname><given-names>J</given-names></name><name><surname>Grimalt</surname><given-names>J</given-names></name><name><surname>Sunyer</surname><given-names>J</given-names></name></person-group><year>2000</year><article-title>Excretion of hexachlorobenzene and metabolites in feces in a highly exposed human population</article-title><source>Environ Health Perspect</source><volume>108</volume><fpage>595</fpage><lpage>598</lpage></element-citation></ref><ref id="R23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toms</surname><given-names>LML</given-names></name><name><surname>Sjodin</surname><given-names>A</given-names></name><name><surname>Harden</surname><given-names>F</given-names></name><name><surname>Hobson</surname><given-names>P</given-names></name><name><surname>Jones</surname><given-names>R</given-names></name><name><surname>Edenfield</surname><given-names>E</given-names></name><name><surname>Mueller</surname><given-names>JF</given-names></name></person-group><year>2009</year><article-title>Serum polybrominated diphenyl ether (PBDE) levels are higher in children (2&#x02013;5 Years of Age) than in infants and adults</article-title><source>Environ Health Perspectives</source><volume>117</volume><issue>9</issue><fpage>1461</fpage><lpage>1465</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1289/ehp.0900596">http://dx.doi.org/10.1289/ehp.0900596</ext-link></comment></element-citation></ref><ref id="R24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toms</surname><given-names>LML</given-names></name><name><surname>Guerra</surname><given-names>P</given-names></name><name><surname>Eljarrat</surname><given-names>E</given-names></name><name><surname>Barcelo</surname><given-names>D</given-names></name><name><surname>Harden</surname><given-names>FA</given-names></name><name><surname>Hobson</surname><given-names>P</given-names></name><etal/></person-group><year>2012</year><article-title>Brominated flame retardants in the Australian population: 1993&#x02013;2009</article-title><source>Chemosphere</source><volume>89</volume><fpage>398</fpage><lpage>403</lpage><pub-id pub-id-type="pmid">22748388</pub-id></element-citation></ref><ref id="R25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaiserman</surname><given-names>A</given-names></name></person-group><year>2015</year><article-title>Epidemiologic evidence for association between adverse environmental exposures in early life and epigenetic variation: a potential link to disease susceptibility?</article-title><source>Clin Epigenetics</source><volume>7</volume><fpage>96</fpage><pub-id pub-id-type="pmid">26366233</pub-id></element-citation></ref><ref id="R26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valvi</surname><given-names>D</given-names></name><name><surname>Mendez</surname><given-names>MA</given-names></name><name><surname>Martinez</surname><given-names>D</given-names></name><name><surname>Grimait</surname><given-names>JO</given-names></name><name><surname>Torrent</surname><given-names>M</given-names></name><name><surname>Sunyer</surname><given-names>J</given-names></name><name><surname>Vrijheid</surname><given-names>M</given-names></name></person-group><year>2012</year><article-title>Prenatal concentrations of polychlorinated biphenyls, DDE, and DDT and overweight in children: a prospective birth cohort study</article-title><source>Environ Health Perspect</source><volume>120</volume><fpage>451</fpage><lpage>457</lpage><pub-id pub-id-type="pmid">22027556</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Linear regression for five chemicals between the log10 transformed (dry-weight based) faecal concentration and (lipid-weight based) plasma concentration (n = 20). The 95% confidence intervals of the linear regressions are shown with dashed lines (details in <xref ref-type="supplementary-material" rid="SD1">Table S11</xref>). Mean LOD for plasma concentrations and mean LOQ for faecal concentrations are also shown.</p></caption><graphic xlink:href="nihms897951f1"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><p>POP concentrations in infants&#x02019; and toddlers&#x02019; plasma and faeces samples.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="top" align="left" colspan="1"/><th colspan="2" valign="bottom" align="left" rowspan="1">POP concentrations in plasma samples<xref rid="TFN1" ref-type="table-fn">a</xref> (n = 20), ng/g lipid
<hr/></th><th colspan="2" valign="bottom" align="left" rowspan="1">POP concentrations in faeces samples<xref rid="TFN4" ref-type="table-fn">d</xref> (n = 20), ng/g dw
<hr/></th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1">QF%<xref rid="TFN2" ref-type="table-fn">b</xref></th><th valign="top" align="left" rowspan="1" colspan="1">GM<xref rid="TFN3" ref-type="table-fn">c</xref> (95% CI)</th><th valign="top" align="left" rowspan="1" colspan="1">QF%</th><th valign="top" align="left" rowspan="1" colspan="1">GM (95% CI)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Lipid content (%)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02013;</td><td valign="top" align="left" rowspan="1" colspan="1">0.52 (0.48, 0.55)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02013;</td><td valign="top" align="left" rowspan="1" colspan="1">11 (9.4, 14)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>p</italic>,<italic>p</italic>&#x02032;-DDE</td><td valign="top" align="left" rowspan="1" colspan="1">100</td><td valign="top" align="left" rowspan="1" colspan="1">100 (55, 180)</td><td valign="top" align="left" rowspan="1" colspan="1">90</td><td valign="top" align="left" rowspan="1" colspan="1">0.61 (0.31, 1.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HCB</td><td valign="top" align="left" rowspan="1" colspan="1">65</td><td valign="top" align="left" rowspan="1" colspan="1">8.8 (6.7, 12)</td><td valign="top" align="left" rowspan="1" colspan="1">90</td><td valign="top" align="left" rowspan="1" colspan="1">0.069 (0.045, 0.11)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x003b2;-HCH</td><td valign="top" align="left" rowspan="1" colspan="1">30</td><td valign="top" align="left" rowspan="1" colspan="1">5.4 (4.5, 6.5)</td><td valign="top" align="left" rowspan="1" colspan="1">40</td><td valign="top" align="left" rowspan="1" colspan="1">0.01 (0.0042, 0.026)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x003b3;-HCH</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">4.3 (3.8, 5.0)</td><td valign="top" align="left" rowspan="1" colspan="1">30</td><td valign="top" align="left" rowspan="1" colspan="1">0.011 (0.0079, 0.016)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PCB28</td><td valign="top" align="left" rowspan="1" colspan="1">20</td><td valign="top" align="left" rowspan="1" colspan="1">1.0 (0.85, 1.3)</td><td valign="top" align="left" rowspan="1" colspan="1">30</td><td valign="top" align="left" rowspan="1" colspan="1">0.026 (0.016, 0.043)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PCB118</td><td valign="top" align="left" rowspan="1" colspan="1">55</td><td valign="top" align="left" rowspan="1" colspan="1">1.8(1.3, 2.7)</td><td valign="top" align="left" rowspan="1" colspan="1">80</td><td valign="top" align="left" rowspan="1" colspan="1">0.042 (0.023, 0.078)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PCB138</td><td valign="top" align="left" rowspan="1" colspan="1">70</td><td valign="top" align="left" rowspan="1" colspan="1">2.7 (1.7, 4.7)</td><td valign="top" align="left" rowspan="1" colspan="1">75</td><td valign="top" align="left" rowspan="1" colspan="1">0.046 (0.023, 0.078)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PCB153</td><td valign="top" align="left" rowspan="1" colspan="1">75</td><td valign="top" align="left" rowspan="1" colspan="1">3.3 (2.0, 5.7)</td><td valign="top" align="left" rowspan="1" colspan="1">75</td><td valign="top" align="left" rowspan="1" colspan="1">0.068 (0.035, 0.13)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PCB180</td><td valign="top" align="left" rowspan="1" colspan="1">55</td><td valign="top" align="left" rowspan="1" colspan="1">2.0 (1.3, 3.0)</td><td valign="top" align="left" rowspan="1" colspan="1">20</td><td valign="top" align="left" rowspan="1" colspan="1">0.019 (0.010, 0.034)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BDE47</td><td valign="top" align="left" rowspan="1" colspan="1">20</td><td valign="top" align="left" rowspan="1" colspan="1">2.5 (2.1, 3.0)</td><td valign="top" align="left" rowspan="1" colspan="1">90</td><td valign="top" align="left" rowspan="1" colspan="1">0.20 (0.11, 0.36)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BDE99</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0.87 (0.75, 1.0)</td><td valign="top" align="left" rowspan="1" colspan="1">45</td><td valign="top" align="left" rowspan="1" colspan="1">0.014 (0.0073, 0.028)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BDE100</td><td valign="top" align="left" rowspan="1" colspan="1">20</td><td valign="top" align="left" rowspan="1" colspan="1">0.99 (0.83, 1.2)</td><td valign="top" align="left" rowspan="1" colspan="1">15</td><td valign="top" align="left" rowspan="1" colspan="1">0.015 (0.010, 0.022)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BDE153</td><td valign="top" align="left" rowspan="1" colspan="1">40</td><td valign="top" align="left" rowspan="1" colspan="1">1.9 (1.4, 2.5)</td><td valign="top" align="left" rowspan="1" colspan="1">20</td><td valign="top" align="left" rowspan="1" colspan="1">0.0092 (0.004, 0.019)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BDE154</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0.87 (0.75, 1.0)</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">0.0019 (0.0015, 0.0022)</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>a</label><p>POPs concentration: LOQ/(2)<sup>1/2</sup> was used for the concentration under quantification limit when the GM was calculated.</p></fn><fn id="TFN2"><label>b</label><p>QF%, quantification frequency (&#x0003e; LOQ).</p></fn><fn id="TFN3"><label>c</label><p>GM: geometric mean.</p></fn><fn id="TFN4"><label>d</label><p>POP concentrations: LOD/(2)<sup>1/2</sup> was used for the concentrations &#x0003c; LOD when the GM was calculated. The average of LOD and LOQ was used for results between LOD and LOQ when the GM was calculated.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float" orientation="landscape"><label>Table 2</label><caption><p>K<sub>fb</sub> ([g lipid]/[g dw]) of three sub-groups for selected POPs.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle" align="left" rowspan="1" colspan="1">Chemicals</th><th valign="middle" align="left" rowspan="1" colspan="1">DDE</th><th valign="middle" align="left" rowspan="1" colspan="1">HCB</th><th valign="middle" align="left" rowspan="1" colspan="1">PCB118</th><th valign="middle" align="left" rowspan="1" colspan="1">PCB138</th><th valign="middle" align="left" rowspan="1" colspan="1">PCB153</th></tr></thead><tbody><tr><td colspan="3" valign="top" align="left" rowspan="1"><italic>The cross-sectional dataset (n = 20)</italic></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Number (&#x0003e; LOQ)</td><td valign="top" align="left" rowspan="1" colspan="1">18</td><td valign="top" align="left" rowspan="1" colspan="1">12</td><td valign="top" align="left" rowspan="1" colspan="1">10</td><td valign="top" align="left" rowspan="1" colspan="1">12</td><td valign="top" align="left" rowspan="1" colspan="1">12</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mean</td><td valign="top" align="left" rowspan="1" colspan="1">0.0081</td><td valign="top" align="left" rowspan="1" colspan="1">0.0099</td><td valign="top" align="left" rowspan="1" colspan="1">0.039</td><td valign="top" align="left" rowspan="1" colspan="1">0.023</td><td valign="top" align="left" rowspan="1" colspan="1">0.027</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Std. deviation</td><td valign="top" align="left" rowspan="1" colspan="1">0.0038</td><td valign="top" align="left" rowspan="1" colspan="1">0.0065</td><td valign="top" align="left" rowspan="1" colspan="1">0.027</td><td valign="top" align="left" rowspan="1" colspan="1">0.013</td><td valign="top" align="left" rowspan="1" colspan="1">0.019</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CV</td><td valign="top" align="left" rowspan="1" colspan="1">46%</td><td valign="top" align="left" rowspan="1" colspan="1">66%</td><td valign="top" align="left" rowspan="1" colspan="1">69%</td><td valign="top" align="left" rowspan="1" colspan="1">58%</td><td valign="top" align="left" rowspan="1" colspan="1">70%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Passed normality test</td><td valign="top" align="left" rowspan="1" colspan="1">YES</td><td valign="top" align="left" rowspan="1" colspan="1">YES</td><td valign="top" align="left" rowspan="1" colspan="1">NO</td><td valign="top" align="left" rowspan="1" colspan="1">YES</td><td valign="top" align="left" rowspan="1" colspan="1">NO</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">5% percentile (P5)</td><td valign="top" align="left" rowspan="1" colspan="1">0.0033</td><td valign="top" align="left" rowspan="1" colspan="1">0.0029</td><td valign="top" align="left" rowspan="1" colspan="1">0.01</td><td valign="top" align="left" rowspan="1" colspan="1">0.0076</td><td valign="top" align="left" rowspan="1" colspan="1">0.0072</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Median</td><td valign="top" align="left" rowspan="1" colspan="1">0.0078</td><td valign="top" align="left" rowspan="1" colspan="1">0.0075</td><td valign="top" align="left" rowspan="1" colspan="1">0.036</td><td valign="top" align="left" rowspan="1" colspan="1">0.022</td><td valign="top" align="left" rowspan="1" colspan="1">0.021</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">95% percentile (P95)</td><td valign="top" align="left" rowspan="1" colspan="1">0.017</td><td valign="top" align="left" rowspan="1" colspan="1">0.023</td><td valign="top" align="left" rowspan="1" colspan="1">0.11</td><td valign="top" align="left" rowspan="1" colspan="1">0.051</td><td valign="top" align="left" rowspan="1" colspan="1">0.073</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">P95/P5</td><td valign="top" align="left" rowspan="1" colspan="1">5.2</td><td valign="top" align="left" rowspan="1" colspan="1">7.9</td><td valign="top" align="left" rowspan="1" colspan="1">11</td><td valign="top" align="left" rowspan="1" colspan="1">6.7</td><td valign="top" align="left" rowspan="1" colspan="1">10</td></tr><tr><td colspan="2" valign="top" align="left" rowspan="1"><italic>Results in adults</italic><xref rid="TFN6" ref-type="table-fn">a</xref>
<italic>(for comparison)</italic></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Number (&#x0003e; LOQ)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02013;</td><td valign="top" align="left" rowspan="1" colspan="1">4</td><td valign="top" align="left" rowspan="1" colspan="1">4</td><td valign="top" align="left" rowspan="1" colspan="1">5</td><td valign="top" align="left" rowspan="1" colspan="1">5</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mean</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02013;</td><td valign="top" align="left" rowspan="1" colspan="1">0.024</td><td valign="top" align="left" rowspan="1" colspan="1">0.023</td><td valign="top" align="left" rowspan="1" colspan="1">0.018</td><td valign="top" align="left" rowspan="1" colspan="1">0.016</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Std. deviation</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02013;</td><td valign="top" align="left" rowspan="1" colspan="1">0.005</td><td valign="top" align="left" rowspan="1" colspan="1">0.013</td><td valign="top" align="left" rowspan="1" colspan="1">0.008</td><td valign="top" align="left" rowspan="1" colspan="1">0.007</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CV</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02013;</td><td valign="top" align="left" rowspan="1" colspan="1">21%</td><td valign="top" align="left" rowspan="1" colspan="1">57%</td><td valign="top" align="left" rowspan="1" colspan="1">44%</td><td valign="top" align="left" rowspan="1" colspan="1">44%</td></tr><tr><td colspan="6" valign="bottom" align="left" rowspan="1">
<hr/></td></tr><tr><td colspan="6" valign="top" align="left" rowspan="1"><italic>The subgroup of participants with two K<sub>fb</sub> vales estimated from two successive bowel movements (n = 7)</italic></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Intra-individual variability (%difference)<xref rid="TFN7" ref-type="table-fn">b</xref></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Min</td><td valign="top" align="left" rowspan="1" colspan="1">12</td><td valign="top" align="left" rowspan="1" colspan="1">11</td><td valign="top" align="left" rowspan="1" colspan="1">0.74</td><td valign="top" align="left" rowspan="1" colspan="1">3.9</td><td valign="top" align="left" rowspan="1" colspan="1">10</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Mean</td><td valign="top" align="left" rowspan="1" colspan="1">45</td><td valign="top" align="left" rowspan="1" colspan="1">42</td><td valign="top" align="left" rowspan="1" colspan="1">42</td><td valign="top" align="left" rowspan="1" colspan="1">44</td><td valign="top" align="left" rowspan="1" colspan="1">42</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Max</td><td valign="top" align="left" rowspan="1" colspan="1">79</td><td valign="top" align="left" rowspan="1" colspan="1">81</td><td valign="top" align="left" rowspan="1" colspan="1">74</td><td valign="top" align="left" rowspan="1" colspan="1">97</td><td valign="top" align="left" rowspan="1" colspan="1">91</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;ICC<xref rid="TFN8" ref-type="table-fn">c</xref> (n)</td><td valign="top" align="left" rowspan="1" colspan="1">0.50 (7)</td><td valign="top" align="left" rowspan="1" colspan="1">0.82 (5)</td><td valign="top" align="left" rowspan="1" colspan="1">0.70 (5)</td><td valign="top" align="left" rowspan="1" colspan="1">0.89 (6)</td><td valign="top" align="left" rowspan="1" colspan="1">0.95 (6)</td></tr><tr><td colspan="6" valign="bottom" align="left" rowspan="1">
<hr/></td></tr><tr><td colspan="5" valign="top" align="left" rowspan="1"><italic>The sub-group of participants with two K<sub>fb</sub> values 5 months apart (n = 13)</italic></td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Intra-individual variability (%difference)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Min</td><td valign="top" align="left" rowspan="1" colspan="1">18</td><td valign="top" align="left" rowspan="1" colspan="1">39</td><td valign="top" align="left" rowspan="1" colspan="1">19</td><td valign="top" align="left" rowspan="1" colspan="1">13</td><td valign="top" align="left" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Mean</td><td valign="top" align="left" rowspan="1" colspan="1">49</td><td valign="top" align="left" rowspan="1" colspan="1">70</td><td valign="top" align="left" rowspan="1" colspan="1">31</td><td valign="top" align="left" rowspan="1" colspan="1">49</td><td valign="top" align="left" rowspan="1" colspan="1">29</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Max</td><td valign="top" align="left" rowspan="1" colspan="1">112</td><td valign="top" align="left" rowspan="1" colspan="1">100</td><td valign="top" align="left" rowspan="1" colspan="1">59</td><td valign="top" align="left" rowspan="1" colspan="1">82</td><td valign="top" align="left" rowspan="1" colspan="1">75</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;ICC (n)</td><td valign="top" align="left" rowspan="1" colspan="1">0.32 (10)</td><td valign="top" align="left" rowspan="1" colspan="1">0.50 (2)</td><td valign="top" align="left" rowspan="1" colspan="1">0.84 (6)</td><td valign="top" align="left" rowspan="1" colspan="1">0.47 (5)</td><td valign="top" align="left" rowspan="1" colspan="1">0.85 (6)</td></tr></tbody></table><table-wrap-foot><fn id="TFN5"><p>&#x02013;: not calculated or not reported due to lack of data.</p></fn><fn id="TFN6"><label>a</label><p>Reference: <xref rid="R14" ref-type="bibr">Moser and McLachlan (2001)</xref>.</p></fn><fn id="TFN7"><label>b</label><p>%Difference.</p></fn><fn id="TFN8"><label>c</label><p>Two-way random absolute agreement ICC was used (single measures are presented here).</p></fn></table-wrap-foot></table-wrap></floats-group></article>